[ Precision Manufacturing for Life-Changing Innovation ]
Life Science
The QMSR took effect February 2, 2026, aligning FDA medical device quality requirements with the internationally recognized ISO 13485 standard for the first time in history. This is not a procedural update. It is a structural shift in how the FDA expects quality systems to be built and demonstrated. Simultaneously, regulatory convergence across FDA, EMA, and ISO frameworks is demanding unified compliance strategies, not siloed responses to each update in isolation.
The pressure to scale production of personalized therapies, combination devices, and high-mix medical assemblies is arriving at exactly the moment that QMSR alignment is demanding digital traceability across the product lifecycle and connected systems are being required to eliminate paper-based gaps.
BOS has engineered precision automation for manufacturers who understand that the margin for error is not a business metric. It is a patient outcome.
BOS modernizes life sciences production through integrated automation systems that synchronize robotics, vision inspection, assembly, and traceability into a single validated production process. The result is equipment reliability, data-backed process control, and sustained manufacturing performance built to meet the compliance demands of FDA, ISO 13485, and GMP environments from day one.
AI embedded in validated systems improves visual inspection, enables predictive maintenance, and optimizes processes while maintaining the control regulated environments require. BOS brings that capability into your production architecture as a designed-in system function through TrueLight.
Today's market leaders in life sciences are define by how seamlessly their systems connect, how quickly they adapt to change, and how reliably they navigate disruption. That adaptability does not come from the most advanced automation platform. It comes from an integration partner who understood your product, your process parameters, and your compliance obligations before they touched a design.
BOS engineers precision assembly, automated inspection, serialization, and traceability systems for medical device, pharmaceutical, and combination product manufacturers navigating high-mix production environments where every SKU carries its own validation history and every batch must be traceable to first principles.
Your production line does not just have to perform. It has to prove it performed. BOS builds both into the same system.
The QMSR took effect February 2, 2026, aligning FDA medical device quality requirements with the internationally recognized ISO 13485 standard for the first time in history. This is not a procedural update. It is a structural shift in how the FDA expects quality systems to be built and demonstrated. Simultaneously, regulatory convergence across FDA, EMA, and ISO frameworks is demanding unified compliance strategies, not siloed responses to each update in isolation.
The pressure to scale production of personalized therapies, combination devices, and high-mix medical assemblies is arriving at exactly the moment that QMSR alignment is demanding digital traceability across the product lifecycle and connected systems are being required to eliminate paper-based gaps.
BOS has engineered precision automation for manufacturers who understand that the margin for error is not a business metric. It is a patient outcome.
BOS modernizes life sciences production through integrated automation systems that synchronize robotics, vision inspection, assembly, and traceability into a single validated production process. The result is equipment reliability, data-backed process control, and sustained manufacturing performance built to meet the compliance demands of FDA, ISO 13485, and GMP environments from day one.
AI embedded in validated systems improves visual inspection, enables predictive maintenance, and optimizes processes while maintaining the control regulated environments require. BOS brings that capability into your production architecture as a designed-in system function through TrueLight.
Today's market leaders in life sciences are define by how seamlessly their systems connect, how quickly they adapt to change, and how reliably they navigate disruption. That adaptability does not come from the most advanced automation platform. It comes from an integration partner who understood your product, your process parameters, and your compliance obligations before they touched a design.
BOS engineers precision assembly, automated inspection, serialization, and traceability systems for medical device, pharmaceutical, and combination product manufacturers navigating high-mix production environments where every SKU carries its own validation history and every batch must be traceable to first principles.
Your production line does not just have to perform. It has to prove it performed. BOS builds both into the same system.
